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CLINICAL INTRODUCTION
A young adult with Friedreich ataxia complaining of exertional breathlessness 
underwent a cardiological evaluation. On physical examination, high blood 
pressure and a loud systolic murmur were noted. ECG showed sinus rhythm 
with voltage criteria for left ventricular hypertrophy (LVH) and T-wave changes 
in the inferolateral leads. Transthoracic echocardiography showed 
biventricular hypertrophy (maximum wall thickness of the interventricular 
septum 26 mm and 16 mm of the posterior wall), preserved systolic function, 
mild left ventricular intracavity gradient and an unremarkable mitral and aortic 
valve. A cardiovascular magnetic resonance (CMR) was requested for further 
assessment. CMR protocol, performed using a 1.5 Tesla scanner, included 
cine images (Fig.1a), native and post contrast T1 mapping (shMOLLI, Fig.1b 
and c), early and late gadolinium enhancement (LGE) images (Fig.1d,e and f). 
Native T1 values were mildly reduced ( ≅ 911 ms) in the septum and low-
normal range (942-974 ms) in the lateral walls. Normal values 962±25 ms at 
1.5 Tesla. Post-contrast T1 values were diffusely reduced. 
Which is the most likely diagnosis based on these findings?
a) Anderson-Fabry’s disease
b) Hypertensive heart disease
c) Hypertrophic cardiomyopathy
d) Myocardial iron load
e) Cardiac amyloidosis
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ANSWER: D
In this case, reduced native T1 values may be explained by a mild cardiac 
iron accumulation, which has been described in autoptic Friedreich ataxia 
hearts(1) . 
Myocardial T1 mapping has been proposed as a method of detection of mild 
iron overload(2). Friedreich ataxia is an inheritable mitochondrial disorder 
caused by the mutation of frataxine. Although the pathophysiology is not 
completely clear, it is commonly accepted that frataxine is involved in 
mitochondrial iron metabolism(3). Cardiac involvement in Friedreich ataxia is a 
leading cause of heart failure and mortality and early tissue mapping changes 
can be detected by CMR(4). Iron mediated cellular damage may represent an 
early stage of cardiomyopathy in these patients.
LVH phenotype can be observed in cardiac amyloidosis, hypertensive heart 
disease and hypertrophic cardiomyopathy. However, none of these conditions 
characteristically exhibit low native T1 values(5), in fact native T1 mapping 
values are usually increased (options B, C and E excluded – Supplementary 
Figure). Moreover, early and LGE images do not show a typical amyloidosis 
pattern. Reduced native T1 values are also observed in lipid accumulation 
(Anderson-Fabry’s disease)(5), but in a patient with a known diagnosis of 
Friedreich’s ataxia, the coexistence f these rare conditions is unlikely.
CMR is a useful tool to investigate cardiac involvement in Friedreich ataxia. 
Further larger studies are needed to confirm these findings.
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a) Basal short axis cine; b) Native T1 mapping basal short axis; c) Post contrast T1 mapping basal short 
axis; d) Early gadolinium enhancement basal short axis; e) Basal short axis  LGE; f) Three-chamber LGE. 
200x134mm (72 x 72 DPI) 
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Supplementary	  Figure	  
	  
	  
	  
	  
	  a)	  Basal	  short	  axis	  cine	  showing	  septal	  hypertrophy	  (maximal	  wall	  thickness	  of	  the	   basal	   anterior	   septum	   20	  mm);	   b)	   Native	   T1	  mapping	   values	   in	   the	   basal	  short	  axis;	   c)	  Post	   contrast	  T1	  mapping	  values	   in	   the	  basal	   short	  axis;	  d)	  Early	  gadolinium	   enhancement	   basal	   short	   axis	   showing	   normal	   gadolinium	  kinetics	  and	   no	   hyperenhancement,	   thus	   excluding	   cardiac	   amyloidosis;	   e)	   Basal	   short	  axis	  showing	  LGE	  in	  the	  lateral	  wall	  (yellow	  arrow);	  f)	  Three-­‐chamber	  showing	  LGE	  un	  the	  lateral	  wall	  (yellow	  arrow).	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